ATE99932T1 - Verwendung von pyrrolicloncarbonsaeurealkylestern zur herstellung eines arzneimittels zur behandlung von ichtyosis. - Google Patents

Verwendung von pyrrolicloncarbonsaeurealkylestern zur herstellung eines arzneimittels zur behandlung von ichtyosis.

Info

Publication number
ATE99932T1
ATE99932T1 AT89304842T AT89304842T ATE99932T1 AT E99932 T1 ATE99932 T1 AT E99932T1 AT 89304842 T AT89304842 T AT 89304842T AT 89304842 T AT89304842 T AT 89304842T AT E99932 T1 ATE99932 T1 AT E99932T1
Authority
AT
Austria
Prior art keywords
treatment
realkylesters
pyrroliclone
ichtyosis
medication
Prior art date
Application number
AT89304842T
Other languages
English (en)
Inventor
Ian Richard Scott
Original Assignee
Unilever Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever Nv filed Critical Unilever Nv
Application granted granted Critical
Publication of ATE99932T1 publication Critical patent/ATE99932T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/008—Preparations for oily skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/28—Rubbing or scrubbing compositions; Peeling or abrasive compositions; Containing exfoliants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrrole Compounds (AREA)
AT89304842T 1988-05-13 1989-05-12 Verwendung von pyrrolicloncarbonsaeurealkylestern zur herstellung eines arzneimittels zur behandlung von ichtyosis. ATE99932T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888811410A GB8811410D0 (en) 1988-05-13 1988-05-13 Treatment of skin disorders
EP89304842A EP0342055B1 (de) 1988-05-13 1989-05-12 Verwendung von Pyrrolicloncarbonsäurealkylestern zur Herstellung eines Arzneimittels zur Behandlung von Ichtyosis

Publications (1)

Publication Number Publication Date
ATE99932T1 true ATE99932T1 (de) 1994-01-15

Family

ID=10636883

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89304842T ATE99932T1 (de) 1988-05-13 1989-05-12 Verwendung von pyrrolicloncarbonsaeurealkylestern zur herstellung eines arzneimittels zur behandlung von ichtyosis.

Country Status (10)

Country Link
US (1) US5045559A (de)
EP (1) EP0342055B1 (de)
JP (1) JPH0217122A (de)
AT (1) ATE99932T1 (de)
AU (1) AU617466B2 (de)
CA (1) CA1324760C (de)
DE (1) DE68912195T2 (de)
ES (1) ES2061989T3 (de)
GB (1) GB8811410D0 (de)
ZA (1) ZA893563B (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2016351C (en) * 1989-05-12 1996-09-03 Walter Thomas Gibson Cosmetic composition
US5455036A (en) * 1990-06-29 1995-10-03 Bode Chemie Method of using cis-urocaninic acid for topically treating psoriasis
US5286720A (en) * 1992-07-16 1994-02-15 Solarcare Technologies Corporation Compositions and methods for topical treatment of skin lesions
GB2313059B (en) * 1993-03-29 1998-01-21 Bioglan Ireland Pharmaceutically useful pyrrolyl derivatives
US5631242A (en) * 1993-08-04 1997-05-20 Patent Biopharmaceutics, Inc. Hyaluronic acid-urea pharmaceutical compositions utilized for treatment of diseases of cutis
US5776920A (en) * 1995-08-02 1998-07-07 Quarles; Ruth Method for treatment of psoriasis
FR2742750B1 (fr) * 1995-12-22 1998-01-30 Oreal Nouveaux derives de l'acide l-2-oxothiazolidine 4-carboxylique et leur utilisation pour le soin de la peau
ITMI20052077A1 (it) * 2005-10-31 2007-05-01 Roda S R L Agente batteriostatica e-o battericida per preparazioni cosmetiche e-o dermofarmaceutiche e preparazioni contenenti questo agente
MX363435B (es) * 2007-03-22 2019-03-22 Berg Llc Formulaciones topicas que tienen biodisponibilidad aumentada.
JP5352100B2 (ja) * 2008-03-12 2013-11-27 株式会社 資生堂 皮膚外用組成物
ES2336995B1 (es) 2008-10-13 2011-02-09 Lipotec, S.A. Composicion cosmetica o dermofarmaceutica para el cuidado de la piel,cuero cabelludo y uñas.
BRPI1010576A2 (pt) 2009-05-11 2016-03-15 Berg Biosystems Llc métodos para tratamento de distúrbios oncológicos usando transferidores epimetabólicos, moléculas intracelulares multidimensionais ou influenciadores ambientais.
WO2011014244A1 (en) 2009-07-28 2011-02-03 St. Jude Medical Puerto Rico Llc Vascular closure device with automatic suture cutter
PT2544663T (pt) * 2010-03-12 2018-04-05 Berg Llc Formulações intravenosas de coenzima q10 (coq10) e métodos de uso da mesma
US8846723B2 (en) * 2010-07-29 2014-09-30 Eastman Chemical Company Esters of O-substituted hydroxy carboxylic acids and preparations thereof
US8613940B2 (en) 2010-09-03 2013-12-24 Eastman Chemical Company Carbonate derivatives as skin care
US8329938B2 (en) 2011-02-21 2012-12-11 Eastman Chemical Company Hydroxyalkanoic acid and hydroxyalkanoice acid oligomer esters of retinol
EP2694463B8 (de) 2011-04-04 2019-10-09 Berg LLC Behandlung von tumoren im zentralnervensystem mit coenzym q10
AU2012271274B2 (en) 2011-06-17 2017-07-27 Berg Llc Inhalable pharmaceutical compositions
US9259343B2 (en) 2012-07-06 2016-02-16 Newman Technologies LLC Device for mitigating plantar fasciitis
JP6595478B2 (ja) 2013-09-04 2019-10-23 バーグ エルエルシー コエンザイムｑ１０の連続注入によるがんの治療方法
WO2017087576A1 (en) 2015-11-16 2017-05-26 Berg Llc Methods of treatment of temozolomide-resistant glioma using coenzyme q10

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3235457A (en) * 1962-12-07 1966-02-15 Gillette Co Humectant
DE2102172C3 (de) * 1971-01-18 1980-03-20 Dr. Karl Thomae Gmbh, 7950 Biberach Neue Mittel zur Behandlung und Pflege der Haut
DE2102171A1 (en) * 1971-01-18 1972-07-27 Dr. Karl Thomae Gmbh, 7950 Biberach Pyrrolidonecarboxylic acid alkyl esters - cosmetic agents
JPS4882046A (de) * 1972-02-02 1973-11-02
JPS536217B2 (de) * 1972-11-30 1978-03-06
LU74438A1 (de) * 1976-02-26 1977-09-12
JPS57185209A (en) * 1981-05-11 1982-11-15 Nisshin Oil Mills Ltd:The Esterified composition and cosmetic containing the same
JPS60214744A (ja) * 1984-04-06 1985-10-28 Nitto Electric Ind Co Ltd 薬物の経皮吸収促進助剤及びこれを含有する外用医薬組成物
GB8421112D0 (en) * 1984-08-20 1984-09-26 Unilever Plc Pyroglutamic acid esters
US4772601A (en) * 1988-01-25 1988-09-20 Hoechst-Roussel Pharmaceuticals, Inc. 5-Substituted 1-(4-(1-pyrrolidinyl)-2-butynyl)-2-pyrrolidinones, pharmaceutical compositions and use

Also Published As

Publication number Publication date
EP0342055A3 (en) 1990-08-29
DE68912195D1 (de) 1994-02-24
EP0342055B1 (de) 1994-01-12
JPH0217122A (ja) 1990-01-22
ES2061989T3 (es) 1994-12-16
EP0342055A2 (de) 1989-11-15
ZA893563B (en) 1991-01-30
GB8811410D0 (en) 1988-06-15
DE68912195T2 (de) 1994-05-19
AU3459689A (en) 1989-11-16
AU617466B2 (en) 1991-11-28
US5045559A (en) 1991-09-03
CA1324760C (en) 1993-11-30

Similar Documents

Publication Publication Date Title
ATE99932T1 (de) Verwendung von pyrrolicloncarbonsaeurealkylestern zur herstellung eines arzneimittels zur behandlung von ichtyosis.
ATE184792T1 (de) 2-bromomelatonin zur behandlung von schlafstörungen
DE69535607D1 (de) Zusammensetzung enthaltend Stickstoffoxid-donatoren und Methode zur Behandlung analer Krankheiten
DE3684190D1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
SE9401406D0 (sv) Pharmaceutical products for curing tumourous diseases and process for preparing same
ATE188118T1 (de) Zusammenfassungen und ihren verwendung in der behandlung von neurologischen krankheiten
ATE429904T1 (de) Topisch anwendbare arzneipräparate und verfahren zur behandlung
DE59607342D1 (de) Verwendung von Prolin als einziger therapeutischer Wirkstoff zur Herstellung eines Arzneimittels zur Behandlung von rheumatischen Erkrankungen und von chronischen und traumatisch bedingten Schmerzzuständen
ATE213411T1 (de) Verwendung von phenserin zur herstellung von medikamenten zur behandlung von kognitiven störungen
ATE186834T1 (de) Verwendung von wirksamen mengen von aktiven stoffen zur behandlung von mischhaut
ATE100320T1 (de) Verwendung von thromboxan-a2-rezeptorantagonisten zur herstellung einer pharmazeutischen zusammensetzung zur behandlung von hautkrankheiten.
EP0214254A1 (de) Melatoninhaltige mittel sowie deren verwendungen.
NO20002649D0 (no) Anvendelse av en blanding av diol og en alfa-hydroksysyre for behandling av hyperkeratotiske hudsykdommer
DE69636778D1 (de) Retinsäurepropyleneglycolester enthaltender Kosmetikum ZUR ANWENDUNG AUF DER HAUT SOWIE ARZNEIMITTEL ZUR BEHANDLUNG VON Hautkrankheiten, TUMORÖSEN ZELLEN UND BLASEN-ODER NERVENSTÖRUNGEN
DE69129563D1 (de) Epidermis-Wachstumsfaktor als Arzneimittel zur Wiederherstellung der Neuronen der Substantia nigra in der Behandlung nervenzerstörender Störungen
DE59304087D1 (de) Placentaextrakt und Verfahren zu seiner Herstellung
EA199900862A1 (ru) Способ лечения сосудистых нарушений
DE69300037D1 (de) Verwendung von Bucillamin zur Herstellung eines Arzneimittels zur Behandlung von Cystinuria.
ATE173921T1 (de) Verwendung von deoxyspergualin zur herstellung eines arzneimittels zur behandlung von entzündlich-hyperreaktiven erkrankungen
ATE196599T1 (de) Mittel zur topischen anwendung auf der haut zur behandlung und/oder zur verhütung von, durch strahlen verursachten hautschäden
KR920009403A (ko) 수면장해 치료용 이미다조벤조디아제핀
DE69825322D1 (de) Topische carbamazepin-formulierungen und deren verwendung
RU94004116A (ru) Способ лечения розовых угрей
HK1004889A1 (en) Pharmaceutical formulations containing vincamine for treatment of peripheral vascular diseases
ATE56360T1 (de) Zusammensetzung zur herstellung eines arzneimittels zur therapeutischen behandlung von hauttrauma.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time